h lundbeck a/s (LUN:Copenhagen)
Earnings & Estimates Summary - H LUNDBECK A/S (LUN)
2013 revenues at H. Lundbeck A/S totaled kr15.3B DKK, while annual earnings equaled kr7.64 per share.
Quarterly Earnings & Estimates - H LUNDBECK A/S (LUN)
H. Lundbeck A/S's Quarterly Earnings
H. Lundbeck A/S reported 1st quarter 2014 earnings of kr1.69 per share on 05/9/2014.
Annual Earnings & Estimates - H LUNDBECK A/S (LUN)
H. Lundbeck A/S's Annual Earnings
H. Lundbeck A/S reported annual 2013 earnings of kr7.64 per share on 02/8/2014.
Quarterly Revenues - H LUNDBECK A/S (LUN)
H. Lundbeck A/S's Quarterly Revenues
H. Lundbeck A/S had 1st quarter 2014 revenues of kr3.6B DKK. This missed the kr3.7B DKK consensus estimate of the 7 analysts following the company. This was -21.6% below the prior year's 1st quarter results.
Annual Revenues - H LUNDBECK A/S (LUN)
H. Lundbeck A/S's Annual Revenues
H. Lundbeck A/S had revenues for the full year 2013 of kr15.3B DKK. This was 3.1% above the prior year's results.
|Alkermes PLC||$48.38 USD||+0.58|
|Emergent Biosolutions Inc||$22.97 USD||+0.06|
|Lupin Ltd||1,053 INR||+13.80|
|Nektar Therapeutics||$12.58 USD||+0.29|
|Salix Pharmaceuticals Ltd||$131.81 USD||-2.03|
|View Industry Companies|